{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:02:08Z","timestamp":1793296928463,"version":"4.5.0"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00210-021-02161-8","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T05:11:31Z","timestamp":1633065091000},"page":"2197-2222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Coenzyme Q10 a mitochondrial restorer for various brain disorders"],"prefix":"10.1007","volume":"394","author":[{"given":"Nilima","family":"Pradhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5168-4930","authenticated-orcid":false,"given":"Arti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"issue":"12","key":"2161_CR1","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1002\/mds.22408","volume":"25","author":"HSGPC Investigators","year":"2010","unstructured":"HSGPC Investigators (2010) Safety and tolerability of high-dosage coenzyme Q10 in Huntington\u2019s disease and healthy subjects. Movement Disorders. 25(12):1924\u20138","journal-title":"Movement Disorders."},{"key":"2161_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pbb.2012.12.027","volume":"104","author":"S Aboul-Fotouh","year":"2013","unstructured":"Aboul-Fotouh S (2013) Coenzyme Q10 displays antidepressant-like activity with reduction of hippocampal oxidative\/nitrosative DNA damage in chronically stressed rats. Pharmacol Biochem Behav 104:105\u2013112","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"2161_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11481-016-9712-7","volume":"12","author":"SA Abuelezz","year":"2017","unstructured":"Abuelezz SA, Hendawy N, Magdy Y (2017) Targeting oxidative stress, cytokines and serotonin interactions via indoleamine 2, 3 dioxygenase by coenzyme Q10: role in suppressing depressive like behavior in rats. J Neuroimmune Pharmacol 12(2):277\u2013291","journal-title":"J Neuroimmune Pharmacol"},{"issue":"2","key":"2161_CR4","first-page":"958","volume":"61","author":"A Ahmadi","year":"2018","unstructured":"Ahmadi A, Haghighi AH, Nikkhah K, Askari R (2018) The effect of eight weeks combined exercise training and coenzyme Q10 supplementation on motor function in patients with multiple sclerosis. Medical Journal of Mashhad University of Medical Sciences 61(2):958\u2013970","journal-title":"Medical Journal of Mashhad University of Medical Sciences"},{"issue":"1","key":"2161_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2202-15-34","volume":"15","author":"M Al-Ghamdi","year":"2014","unstructured":"Al-Ghamdi M, Al-Ayadhi L, El-Ansary A (2014) Selected biomarkers as predictive tools in testing efficacy of melatonin and coenzyme Q on propionic acid-induced neurotoxicity in rodent model of autism. BMC Neurosci 15(1):1\u201310","journal-title":"BMC Neurosci"},{"key":"2161_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3389\/fnins.2018.00386","volume":"12","author":"J Allen","year":"2018","unstructured":"Allen J, Romay-Tallon R, Brymer KJ, Caruncho HJ, Kalynchuk LE (2018) Mitochondria and mood: mitochondrial dysfunction as a key player in the manifestation of depression. Front Neurosci 12:386","journal-title":"Front Neurosci"},{"issue":"5","key":"2161_CR7","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1007\/s11064-019-02761-0","volume":"44","author":"S Andalib","year":"2019","unstructured":"Andalib S, Mashhadi-Mousapour M, Bijani S, Hosseini M-J (2019) Coenzyme Q 10 alleviated behavioral dysfunction and bioenergetic function in an animal model of depression. Neurochem Res 44(5):1182\u20131191","journal-title":"Neurochem Res"},{"issue":"4","key":"2161_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/archgenpsychiatry.2010.22","volume":"67","author":"AC Andreazza","year":"2010","unstructured":"Andreazza AC, Shao L, Wang J-F, Young LT (2010) Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry 67(4):360\u2013368","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"2161_CR9","doi-asserted-by":"publisher","first-page":"e22519","DOI":"10.1002\/jbt.22519","volume":"34","author":"H Attia","year":"2020","unstructured":"Attia H, Albuhayri S, Alaraidh S, Alotaibi A, Yacoub H, Mohamad R et al (2020) Biotin, coenzyme Q10, and their combination ameliorate aluminium chloride-induced Alzheimer\u2019s disease via attenuating neuroinflammation and improving brain insulin signaling. J Biochem Molec Toxicol. 34(9):e22519","journal-title":"J Biochem Molec Toxicol."},{"issue":"5319","key":"2161_CR10","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1126\/science.276.5319.1709","volume":"276","author":"M Babcock","year":"1997","unstructured":"Babcock M, de Silva D, Oaks R, Davis-Kaplan S, Jiralerspong S, Montermini L et al (1997) Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 276(5319):1709\u20131712","journal-title":"Science"},{"issue":"2","key":"2161_CR11","first-page":"120","volume":"9","author":"S B\u0103descu","year":"2016","unstructured":"B\u0103descu S, T\u0103taru C, Kobylinska L, Georgescu E, Zahiu D, Z\u0103grean A et al (2016) The association between diabetes mellitus and depression. J Med Life 9(2):120","journal-title":"J Med Life"},{"issue":"5","key":"2161_CR12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.tibs.2011.01.004","volume":"36","author":"BM Baker","year":"2011","unstructured":"Baker BM, Haynes CM (2011) Mitochondrial protein quality control during biogenesis and aging. Trends Biochem Sci 36(5):254\u2013261","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"2161_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/imm.12443","volume":"144","author":"N Bakunina","year":"2015","unstructured":"Bakunina N, Pariante CM, Zunszain PA (2015) Immune mechanisms linked to depression via oxidative stress and neuroprogression. Immunology 144(3):365\u2013373","journal-title":"Immunology"},{"issue":"1","key":"2161_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12031-012-9886-2","volume":"49","author":"T Baluchnejadmojarad","year":"2013","unstructured":"Baluchnejadmojarad T, Roghani M (2013) Coenzyme q10 ameliorates neurodegeneration, mossy fiber sprouting, and oxidative stress in intrahippocampal kainate model of temporal lobe epilepsy in rat. J Mol Neurosci 49(1):194\u2013201","journal-title":"J Mol Neurosci"},{"issue":"6","key":"2161_CR15","doi-asserted-by":"publisher","first-page":"610","DOI":"10.2174\/1570159X14666160229114755","volume":"14","author":"Y Bansal","year":"2016","unstructured":"Bansal Y, Kuhad A (2016) Mitochondrial dysfunction in depression. Curr Neuropharmacol 14(6):610\u2013618","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"2161_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/biology8020037","volume":"8","author":"IP Barcelos","year":"2018","unstructured":"Barcelos IP, Troxell RM, Graves JS (2018) Mitochondrial dysfunction and multiple sclerosis. Biology 8(2):37","journal-title":"Biology"},{"issue":"10","key":"2161_CR17","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","volume":"13","author":"MF Beal","year":"1993","unstructured":"Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller J et al (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13(10):4181\u20134192","journal-title":"J Neurosci"},{"issue":"6","key":"2161_CR18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/ana.410360613","volume":"36","author":"MF Beal","year":"1994","unstructured":"Beal MF, Henshaw DR, Jenkins BG, Rosen BR, Schulz JB (1994) Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Ann Neurol 36(6):882\u2013888","journal-title":"Ann Neurol"},{"issue":"1","key":"2161_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0006-8993(97)01192-X","volume":"783","author":"MF Beal","year":"1998","unstructured":"Beal MF, Matthews RT, Tieleman A, Shults CW (1998) Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice. Brain Res 783(1):109\u2013114","journal-title":"Brain Res"},{"issue":"22","key":"2161_CR20","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1093\/eurheartj\/ehl158","volume":"27","author":"R Belardinelli","year":"2006","unstructured":"Belardinelli R, Mu\u00e7aj A, Lacalaprice F, Solenghi M, Seddaiu G, Principi F et al (2006) Coenzyme Q10 and exercise training in chronic heart failure. Eur Heart J 27(22):2675\u20132681","journal-title":"Eur Heart J"},{"issue":"4","key":"2161_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1017\/S1461145799001649","volume":"2","author":"D Ben-Shachar","year":"1999","unstructured":"Ben-Shachar D, Zuk R, Gazawi H, Reshef A, Sheinkman A, Klein E (1999) Increased mitochondrial complex I activity in platelets of schizophrenic patients. Int J Neuropsychopharmacol 2(4):245\u2013253","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"2161_CR22","first-page":"161","volume":"9","author":"B Bergamasco","year":"1994","unstructured":"Bergamasco B, Scarzella L, La Commare P (1994) Idebenone, a new drug in the treatment of cognitive impairment in patients with dementia of the Alzheimer type. Funct Neurol 9(3):161\u2013168","journal-title":"Funct Neurol"},{"issue":"3","key":"2161_CR23","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","volume":"35","author":"M Berk","year":"2011","unstructured":"Berk M, Kapczinski F, Andreazza AC, Dean O, Giorlando F, Maes M et al (2011) Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 35(3):804\u2013817","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"2161_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/10715760600617843","volume":"40","author":"HN Bhagavan","year":"2006","unstructured":"Bhagavan HN, Chopra RK (2006) Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radical Res 40(5):445\u2013453","journal-title":"Free Radical Res"},{"issue":"6","key":"2161_CR25","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.pharep.2016.07.005","volume":"68","author":"M Bhardwaj","year":"2016","unstructured":"Bhardwaj M, Kumar A (2016) Neuroprotective mechanism of coenzyme Q10 (CoQ10) against PTZ induced kindling and associated cognitive dysfunction: possible role of microglia inhibition. Pharmacol Rep 68(6):1301\u20131311","journal-title":"Pharmacol Rep"},{"key":"2161_CR26","doi-asserted-by":"crossref","unstructured":"Bhatt S, Nagappa AN, Patil CR. Role of oxidative stress in depression. Drug discovery today. 2020.","DOI":"10.1016\/j.drudis.2020.05.001"},{"issue":"4","key":"2161_CR27","doi-asserted-by":"publisher","first-page":"602","DOI":"10.2105\/AJPH.90.4.602","volume":"90","author":"RV Bijl","year":"2000","unstructured":"Bijl RV, Ravelli A (2000) Psychiatric morbidity, service use, and need for care in the general population: results of The Netherlands Mental Health Survey and Incidence Study. Am J Public Health 90(4):602","journal-title":"Am J Public Health"},{"issue":"6","key":"2161_CR28","first-page":"1065","volume":"72","author":"RA Bonakdar","year":"2005","unstructured":"Bonakdar RA, Guarneri E (2005) Coenzyme Q10. Am Fam Physician 72(6):1065\u20131070","journal-title":"Am Fam Physician"},{"key":"2161_CR29","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.410410514","volume":"41","author":"S Browne","year":"1997","unstructured":"Browne S, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM, Bird ED, Beal MF (1997) Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: selective vulnerability of the basal ganglia. Ann Neurol 41:646\u2013653","journal-title":"Ann Neurol"},{"issue":"10","key":"2161_CR30","first-page":"1935","volume":"70","author":"PA Calabresi","year":"2004","unstructured":"Calabresi PA (2004) Diagnosis and management of multiple sclerosis. Am Fam Physician 70(10):1935\u20131944","journal-title":"Am Fam Physician"},{"key":"2161_CR31","unstructured":"Cambridge H. MA: HDF Biennial Symposia; 2005. PRE2CARE: a dosage ranging trial of coenzyme Q10 in Huntington\u2019s disease and normal subjects."},{"issue":"4","key":"2161_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuint.2005.10.011","volume":"48","author":"HJ Choi","year":"2006","unstructured":"Choi HJ, Lee SY, Cho Y, No H, Kim SW, Hwang O (2006) Tetrahydrobiopterin causes mitochondrial dysfunction in dopaminergic cells: implications for Parkinson\u2019s disease. Neurochem Int 48(4):255\u2013262","journal-title":"Neurochem Int"},{"issue":"6","key":"2161_CR33","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1111\/j.1471-4159.2007.05097.x","volume":"104","author":"C Cleren","year":"2008","unstructured":"Cleren C, Yang L, Lorenzo B, Calingasan NY, Schomer A, Sireci A et al (2008) Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism. J Neurochem 104(6):1613\u20131621","journal-title":"J Neurochem"},{"issue":"3","key":"2161_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S1474-4422(15)00151-9","volume":"15","author":"JN Constantino","year":"2016","unstructured":"Constantino JN, Charman T (2016) Diagnosis of autism spectrum disorder: reconciling the syndrome, its diverse origins, and variation in expression. The Lancet Neurology 15(3):279\u2013291","journal-title":"The Lancet Neurology"},{"issue":"1","key":"2161_CR35","first-page":"77","volume":"14","author":"J Cooper","year":"2009","unstructured":"Cooper J, Korlipara L, Hart P (2009) Coenzyme Q10 and vitamin E deficiency in Friedreich\u2019s ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy. Altern Med Rev 14(1):77\u201378","journal-title":"Altern Med Rev"},{"issue":"4","key":"2161_CR36","doi-asserted-by":"publisher","first-page":"e35677","DOI":"10.1371\/journal.pone.0035677","volume":"7","author":"MD Cordero","year":"2012","unstructured":"Cordero MD, Cano-Garc\u00eda FJ, Alcocer-G\u00f3mez E, De Miguel M, S\u00e1nchez-Alc\u00e1zar JA (2012) Oxidative stress correlates with headache symptoms in fibromyalgia: coenzyme Q 10 effect on clinical improvement. PloS one. 7(4):e35677","journal-title":"PloS one."},{"key":"2161_CR37","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2013.5260","volume-title":"Can coenzyme q10 improve clinical and molecular parameters in fibromyalgia?","author":"MD Cordero","year":"2013","unstructured":"Cordero MD, Alcocer-G\u00f3mez E, de Miguel M, Culic O, Carri\u00f3n AM, Alvarez-Suarez JM et al (2013) Can coenzyme q10 improve clinical and molecular parameters in fibromyalgia? Mary Ann Liebert Inc, New Rochelle"},{"issue":"2","key":"2161_CR38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pneurobio.2011.06.003","volume":"97","author":"M Cozzolino","year":"2012","unstructured":"Cozzolino M, Carr\u00ec MT (2012) Mitochondrial dysfunction in ALS. Prog Neurobiol 97(2):54\u201366","journal-title":"Prog Neurobiol"},{"issue":"6","key":"2161_CR39","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/07315724.2001.10719063","volume":"20","author":"FL Crane","year":"2001","unstructured":"Crane FL (2001) Biochemical functions of coenzyme Q10. J Am Coll Nutr 20(6):591\u2013598","journal-title":"J Am Coll Nutr"},{"key":"2161_CR40","first-page":"1","volume":"4","author":"VA Cwik","year":"2001","unstructured":"Cwik VA (2001) What is amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis: a Guide for Patients and Families 4:1\u201316","journal-title":"Amyotrophic Lateral Sclerosis: a Guide for Patients and Families"},{"issue":"3\u20134","key":"2161_CR41","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0891-5849(00)00307-5","volume":"29","author":"G Dallner","year":"2000","unstructured":"Dallner G, Sindelar PJ (2000) Regulation of ubiquinone metabolism. Free Radical Biol Med 29(3\u20134):285\u2013294","journal-title":"Free Radical Biol Med"},{"issue":"3","key":"2161_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1034\/j.1600-0404.2000.101003209.x","volume":"101","author":"F De Bustos","year":"2000","unstructured":"De Bustos F, Jim\u00e9nez-Jim\u00e9nez F, Molina J, G\u00f3mez-Escalonilla C, De Andres C, Del Hoyo P et al (2000) Serum levels of coenzyme Q10 in patients with multiple sclerosis. Acta Neurol Scand 101(3):209\u2013211","journal-title":"Acta Neurol Scand"},{"issue":"10","key":"2161_CR43","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S1474-4422(07)70220-X","volume":"6","author":"NA Di Prospero","year":"2007","unstructured":"Di Prospero NA, Baker A, Jeffries N, Fischbeck KH (2007) Neurological effects of high-dose idebenone in patients with Friedreich\u2019s ataxia: a randomised, placebo-controlled trial. The Lancet Neurology 6(10):878\u2013886","journal-title":"The Lancet Neurology"},{"issue":"26","key":"2161_CR44","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1056\/NEJMra022567","volume":"348","author":"S DiMauro","year":"2003","unstructured":"DiMauro S, Schon EA (2003) Mitochondrial respiratory-chain diseases. N Engl J Med 348(26):2656\u20132668","journal-title":"N Engl J Med"},{"issue":"3","key":"2161_CR45","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1172\/JCI31423","volume":"117","author":"S DiMauro","year":"2007","unstructured":"DiMauro S, Quinzii CM, Hirano M (2007) Mutations in coenzyme Q 10 biosynthetic genes. J Clin Investig 117(3):587\u2013589","journal-title":"J Clin Investig"},{"issue":"2","key":"2161_CR46","first-page":"719","volume":"15","author":"HRD Dolatabadi","year":"2012","unstructured":"Dolatabadi HRD, Reisi P, Alaei H, Malekabadi HA, Pilehvarian AA (2012) Folic acid and coenzyme Q10 ameliorate cognitive dysfunction in the rats with intracerebroventricular injection of streptozotocin. Iran J Basic Med Sci 15(2):719","journal-title":"Iran J Basic Med Sci"},{"issue":"7","key":"2161_CR47","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1212\/WNL.43.7.1377","volume":"43","author":"R Duara","year":"1993","unstructured":"Duara R, Lopez-Alberola R, Barker W, Loewenstein D, Zatinsky M, Eisdorfer C et al (1993) A comparison of familial and sporadic Alzheimer\u2019s disease. Neurology. 43(7):1377","journal-title":"Neurology."},{"issue":"1","key":"2161_CR48","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3233\/JAD-2011-110209","volume":"27","author":"M Dumont","year":"2011","unstructured":"Dumont M, Kipiani K, Yu F, Wille E, Katz M, Calingasan NY et al (2011) Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer\u2019s disease. J Alzheimers Dis 27(1):211\u2013223","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"2161_CR49","first-page":"11","volume":"14","author":"S Ebrahimi","year":"2019","unstructured":"Ebrahimi S, Haghighi A, Nikkhah K, Hamidi H (2019) Effects of coenzyme Q10 supplementation on antioxidant enzyme and lipid peroxide activities in women with multiple sclerosis: a randomized, placebo-controlled trial. Iranian Journal of Nutrition Sciences & Food Technology 14(3):11\u201320","journal-title":"Iranian Journal of Nutrition Sciences & Food Technology"},{"issue":"2","key":"2161_CR50","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.yebeh.2012.06.016","volume":"25","author":"MJ England","year":"2012","unstructured":"England MJ, Liverman CT, Schultz AM, Strawbridge LM (2012) Epilepsy across the spectrum: promoting health and understanding: a summary of the Institute of Medicine report. Epilepsy Behav 25(2):266\u2013276","journal-title":"Epilepsy Behav"},{"key":"2161_CR51","unstructured":"Moccia M, Capacchione A, Lanzillo R, Carbone F, Sacc\u00e0 F, De Rosa A, et al. Oxidative stress in multiple sclerosis\": effect of dietary supplementation with coenzyme Q10. Presented at Italian Society of Neurology. 2017."},{"issue":"3","key":"2161_CR52","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/mds.870110317","volume":"11","author":"A Feigin","year":"1996","unstructured":"Feigin A, Kieburtz K, Como P, Hickey C, Abwender D, Zimmerman C et al (1996) Assessment of coenzyme Q10 tolerability in Huntington\u2019s disease. Movement Disorders 11(3):321\u2013323","journal-title":"Movement Disorders"},{"issue":"5","key":"2161_CR53","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","volume":"22","author":"RJ Ferrante","year":"2002","unstructured":"Ferrante RJ, Andreassen OA, Dedeoglu A, Ferrante KL, Jenkins BG, Hersch SM et al (2002) Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington\u2019s disease. J Neurosci 22(5):1592\u20131599","journal-title":"J Neurosci"},{"issue":"11","key":"2161_CR54","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1212\/01.wnl.0000187070.35365.d7","volume":"65","author":"K Ferrante","year":"2005","unstructured":"Ferrante K, Shefner J, Zhang H, Betensky R, O\u2019brien M, Yu H et al (2005) Tolerance of high-dose (3,000 mg\/day) coenzyme Q10 in ALS. Neurology. 65(11):1834\u20136","journal-title":"Neurology."},{"issue":"5","key":"2161_CR55","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1017\/S2040174416000246","volume":"7","author":"D Ferreira","year":"2016","unstructured":"Ferreira D, Sellitti D, Lagranha C (2016) Protein undernutrition during development and oxidative impairment in the central nervous system (CNS): potential factors in the occurrence of metabolic syndrome and CNS disease. J Dev Orig Health Dis 7(5):513\u2013524","journal-title":"J Dev Orig Health Dis"},{"key":"2161_CR56","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.brainres.2008.12.027","volume":"1257","author":"AR Fetoni","year":"2009","unstructured":"Fetoni AR, Piacentini R, Fiorita A, Paludetti G, Troiani D (2009) Water-soluble coenzyme Q10 formulation (Q-ter) promotes outer hair cell survival in a guinea pig model of noise induced hearing loss (NIHL). Brain Res 1257:108\u2013116","journal-title":"Brain Res"},{"issue":"6","key":"2161_CR57","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/088307380201700607","volume":"17","author":"JJ Filiano","year":"2002","unstructured":"Filiano JJ, Goldenthal MJ, Harker Rhodes C, Marin-Garcia J (2002) Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome. J Child Neurol 17(6):435\u2013439","journal-title":"J Child Neurol"},{"issue":"1","key":"2161_CR58","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.mito.2011.04.004","volume":"12","author":"J Folbergrov\u00e1","year":"2012","unstructured":"Folbergrov\u00e1 J, Kunz WS (2012) Mitochondrial dysfunction in epilepsy. Mitochondrion 12(1):35\u201340","journal-title":"Mitochondrion"},{"issue":"2","key":"2161_CR59","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","volume":"66","author":"PT Francis","year":"1999","unstructured":"Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimer\u2019s disease: a review of progress. J Neurol Neurosurg Psychiatry 66(2):137\u2013147","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2161_CR60","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mcn.2018.06.005","volume":"92","author":"J Fronti\u00f1\u00e1n-Rubio","year":"2018","unstructured":"Fronti\u00f1\u00e1n-Rubio J, Sancho-Bielsa FJ, Peinado JR, LaFerla FM, Gim\u00e9nez-Llort L, Dur\u00e1n-Prado M et al (2018) Sex-dependent co-occurrence of hypoxia and \u03b2-amyloid plaques in hippocampus and entorhinal cortex is reversed by long-term treatment with ubiquinol and ascorbic acid in the 3\u00d7 Tg-AD mouse model of Alzheimer\u2019s disease. Mol Cell Neurosci 92:67\u201381","journal-title":"Mol Cell Neurosci"},{"issue":"7","key":"2161_CR61","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/archneurol.2012.85","volume":"69","author":"DR Galasko","year":"2012","unstructured":"Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA et al (2012) Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch Neurol 69(7):836\u2013841","journal-title":"Arch Neurol"},{"issue":"4","key":"2161_CR62","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2741\/4231","volume":"19","author":"J Garrido-Maraver","year":"2014","unstructured":"Garrido-Maraver J, Cordero MD, Oropesa-Avila M, Vega AF, de la Mata M, Pavon AD et al (2014) Clinical applications of coenzyme Q10. Front Biosci (landmark Ed) 19(4):619\u2013633","journal-title":"Front Biosci (landmark Ed)"},{"issue":"6","key":"2161_CR63","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00127-018-1512-3","volume":"53","author":"D Gibson-Smith","year":"2018","unstructured":"Gibson-Smith D, Bot M, Snijder M, Nicolaou M, Derks EM, Stronks K et al (2018) The relation between obesity and depressed mood in a multi-ethnic population. The HELIUS study. Social Psychiat Psychiatr epidemiol. 53(6):629\u201338","journal-title":"Social Psychiat Psychiatr epidemiol."},{"issue":"3","key":"2161_CR64","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00415-004-0348-9","volume":"251","author":"Y Gilgun-Sherki","year":"2004","unstructured":"Gilgun-Sherki Y, Melamed E, Offen D (2004) The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 251(3):261\u2013268","journal-title":"J Neurol"},{"issue":"1","key":"2161_CR65","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1212\/WNL.28.1.23","volume":"28","author":"HH Goebel","year":"1978","unstructured":"Goebel HH, Heipertz R, Scholz W, Iqbal K, Tellez-nagel I (1978) Juvenile Huntington chorea: clinical, ultrastructural, and biochemical studies. Neurology. 28(1):23","journal-title":"Neurology."},{"issue":"3","key":"2161_CR66","first-page":"175","volume":"37","author":"MM Goldenberg","year":"2012","unstructured":"Goldenberg MM (2012) Multiple Sclerosis Review Pharmacy and Therapeutics 37(3):175","journal-title":"Multiple Sclerosis Review Pharmacy and Therapeutics"},{"issue":"1","key":"2161_CR67","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cns.12655","volume":"23","author":"M Golpich","year":"2017","unstructured":"Golpich M, Amini E, Mohamed Z, Azman Ali R, Mohamed Ibrahim N, Ahmadiani A (2017) Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: pathogenesis and treatment. CNS Neurosci Ther 23(1):5\u201322","journal-title":"CNS Neurosci Ther"},{"issue":"10027","key":"2161_CR68","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","volume":"387","author":"I Grande","year":"2016","unstructured":"Grande I, Berk M, Birmaher B, Vieta E (2016) Bipolar disorder. The Lancet 387(10027):1561\u20131572","journal-title":"The Lancet"},{"issue":"3","key":"2161_CR69","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1212\/WNL.57.3.397","volume":"57","author":"Group HS","year":"2001","unstructured":"Group HS (2001) A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington\u2019s disease. Neurology 57(3):397\u2013404","journal-title":"Neurology"},{"issue":"3","key":"2161_CR70","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ana.410390317","volume":"39","author":"M Gu","year":"1996","unstructured":"Gu M, Gash M, Mann V, Javoy-Agid F, Cooper J, Schapira A (1996) Mitochondrial defect in Huntington\u2019s disease caudate nucleus. Ann Neurol 39(3):385\u2013389","journal-title":"Ann Neurol"},{"key":"2161_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/798957","volume":"2014","author":"A Gvozdj\u00e1kov\u00e1","year":"2014","unstructured":"Gvozdj\u00e1kov\u00e1 A, Kucharsk\u00e1 J, Ostatn\u00edkov\u00e1 D, Babinsk\u00e1 K, Nakl\u00e1dal D, Crane FL (2014) Ubiquinol improves symptoms in children with autism. Oxidative Medicine and Cellular Longevity. 2014:1\u20136","journal-title":"Oxidative Medicine and Cellular Longevity."},{"issue":"6","key":"2161_CR72","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/ana.410370604","volume":"37","author":"RH Haas","year":"1995","unstructured":"Haas RH, Nasirian F, Nakano K, Ward D, Pay M, Hill R et al (1995) Low platelet mitochondrial complex I and complex II\/III activity in early untreated Parkinson\u2019s disease. Ann Neurol 37(6):714\u2013722","journal-title":"Ann Neurol"},{"issue":"4","key":"2161_CR73","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/archneur.62.4.621","volume":"62","author":"PE Hart","year":"2005","unstructured":"Hart PE, Lodi R, Rajagopalan B, Bradley JL, Crilley JG, Turner C et al (2005) Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up. Arch Neurol 62(4):621\u2013626","journal-title":"Arch Neurol"},{"issue":"3","key":"2161_CR74","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/j.2051-5545.2010.tb00298.x","volume":"9","author":"G Hasler","year":"2010","unstructured":"Hasler G (2010) Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World Psychiatry 9(3):155","journal-title":"World Psychiatry"},{"issue":"2","key":"2161_CR75","first-page":"2461","volume":"16","author":"SL Hauser","year":"2005","unstructured":"Hauser SL, Goodin DS (2005) Multiple sclerosis and other demyelinating diseases. Harrisons Principles of Internal Medicine 16(2):2461","journal-title":"Harrisons Principles of Internal Medicine"},{"issue":"5","key":"2161_CR76","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s41386-018-0090-0","volume":"44","author":"L Holper","year":"2019","unstructured":"Holper L, Ben-Shachar D, Mann JJ (2019) Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease. Neuropsychopharmacology 44(5):837\u2013849","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"2161_CR77","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1001\/archneur.60.8.1170-b","volume":"60","author":"MW Horstink","year":"2003","unstructured":"Horstink MW, Van Engelen BG (2003) The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic. Arch Neurol 60(8):1170\u20131172","journal-title":"Arch Neurol"},{"issue":"5","key":"2161_CR78","doi-asserted-by":"publisher","first-page":"5333","DOI":"10.1007\/s11033-019-04989-z","volume":"46","author":"L Jahangard","year":"2019","unstructured":"Jahangard L, Yasrebifar F, Haghighi M, Ranjbar A, Mehrpooya M (2019) Influence of adjuvant coenzyme Q10 on inflammatory and oxidative stress biomarkers in patients with bipolar disorders during the depressive episode. Mol Biol Rep 46(5):5333\u20135343","journal-title":"Mol Biol Rep"},{"issue":"2","key":"2161_CR79","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/ana.21743","volume":"66","author":"P Kaufmann","year":"2009","unstructured":"Kaufmann P, Thompson JL, Levy G, Buchsbaum R, Shefner J, Krivickas LS et al (2009) Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Ann Neurol 66(2):235\u2013244","journal-title":"Ann Neurol"},{"issue":"1","key":"2161_CR80","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2174\/1876396001205010187","volume":"5","author":"T Kawasaki","year":"2012","unstructured":"Kawasaki T, Singh RB, Germaine C, Halberg F (2012) Effects of coenzyme Q10 administration in amyotrophic lateral sclerosis (ALS) Report of a case and review. The Open Nutraceuticals Journal. 5(1):187\u2013192","journal-title":"The Open Nutraceuticals Journal."},{"issue":"19","key":"2161_CR81","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1523\/JNEUROSCI.0984-06.2006","volume":"26","author":"PM Keeney","year":"2006","unstructured":"Keeney PM, Xie J, Capaldi RA, Bennett JP (2006) Parkinson\u2019s disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 26(19):5256\u20135264","journal-title":"J Neurosci"},{"issue":"23","key":"2161_CR82","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","volume":"289","author":"RC Kessler","year":"2003","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR et al (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289(23):3095\u20133105","journal-title":"JAMA"},{"issue":"1","key":"2161_CR83","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10735-020-09929-x","volume":"52","author":"B Khalilian","year":"2021","unstructured":"Khalilian B, Madadi S, Fattahi N, Abouhamzeh B (2021) Coenzyme Q10 enhances remyelination and regulate inflammation effects of cuprizone in corpus callosum of chronic model of multiple sclerosis. J Mol Histol 52(1):125\u2013134","journal-title":"J Mol Histol"},{"issue":"01","key":"2161_CR84","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1055\/s-2008-1076737","volume":"39","author":"D Khurana","year":"2008","unstructured":"Khurana D, Salganicoff L, Melvin J, Hobdell E, Valencia I, Hardison H et al (2008) Epilepsy and respiratory chain defects in children with mitochondrial encephalopathies. Neuropediatrics 39(01):8\u201313","journal-title":"Neuropediatrics"},{"issue":"9769","key":"2161_CR85","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O et al (2011) Amyotrophic lateral sclerosis. The Lancet 377(9769):942\u2013955","journal-title":"The Lancet"},{"issue":"6676","key":"2161_CR86","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S et al (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 392(6676):605\u20138","journal-title":"Nature."},{"key":"2161_CR87","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.brainresbull.2019.01.025","volume":"147","author":"H Komaki","year":"2019","unstructured":"Komaki H, Faraji N, Komaki A, Shahidi S, Etaee F, Raoufi S et al (2019) Investigation of protective effects of coenzyme Q10 on impaired synaptic plasticity in a male rat model of Alzheimer\u2019s disease. Brain Res Bull 147:14\u201321","journal-title":"Brain Res Bull"},{"issue":"2","key":"2161_CR88","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ana.410410206","volume":"41","author":"WJ Koroshetz","year":"1997","unstructured":"Koroshetz WJ, Jenkins BG, Rosen BR, Beal MF (1997) Energy metabolism defects in Huntington\u2019s disease and effects of coenzyme Q10. Ann Neurol 41(2):160\u2013165","journal-title":"Ann Neurol"},{"issue":"2","key":"2161_CR89","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S2215-0366(16)30263-2","volume":"4","author":"C Kuehner","year":"2017","unstructured":"Kuehner C (2017) Why is depression more common among women than among men? The Lancet Psychiatry 4(2):146\u2013158","journal-title":"The Lancet Psychiatry"},{"issue":"5","key":"2161_CR90","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/1531-8249(200011)48:5<766::AID-ANA10>3.0.CO;2-M","volume":"48","author":"WS Kunz","year":"2000","unstructured":"Kunz WS, Kudin AP, Vielhaber S, Bl\u00fcmcke I, Zuschratter W, Schramm J et al (2000) Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy. Ann Neurol 48(5):766\u2013773","journal-title":"Ann Neurol"},{"issue":"4587","key":"2161_CR91","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219(4587):979\u2013980","journal-title":"Science"},{"issue":"14","key":"2161_CR92","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.addr.2009.07.016","volume":"61","author":"J Lee","year":"2009","unstructured":"Lee J, Boo JH, Ryu H (2009) The failure of mitochondria leads to neurodegeneration: do mitochondria need a jump start? Adv Drug Deliv Rev 61(14):1316\u20131323","journal-title":"Adv Drug Deliv Rev"},{"key":"2161_CR93","doi-asserted-by":"crossref","unstructured":"Legido A, Goldenthal M, Garvin B, Damle S, Corrigan K, Connell J, et al. Effect of a combination of carnitine, coenzyme Q10 and alpha-lipoic acid (MitoCocktail) on mitochondrial function and neurobehavioral performance in children with autism spectrum disorder (P3. 313). AAN Enterprises; 2018.","DOI":"10.1212\/WNL.90.15_supplement.P3.313"},{"issue":"6701","key":"2161_CR94","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/26652","volume":"395","author":"E Leroy","year":"1998","unstructured":"Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E et al (1998) The ubiquitin pathway in Parkinson\u2019s disease. Nature 395(6701):451\u2013452","journal-title":"Nature"},{"issue":"1\u20134","key":"2161_CR95","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/biof.5520320120","volume":"32","author":"G Li","year":"2008","unstructured":"Li G, Jack CR, Yang XF, Yang ES (2008) Diet supplement CoQ10 delays brain atrophy in aged transgenic mice with mutations in the amyloid precursor protein: an in vivo volume MRI study. BioFactors 32(1\u20134):169\u2013178","journal-title":"BioFactors"},{"issue":"1","key":"2161_CR96","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12033-007-0052-y","volume":"37","author":"GP Littarru","year":"2007","unstructured":"Littarru GP, Tiano L (2007) Bioenergetic and antioxidant properties of coenzyme Q 10: recent developments. Mol Biotechnol 37(1):31\u201337","journal-title":"Mol Biotechnol"},{"issue":"2","key":"2161_CR97","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0022-510X(00)00343-9","volume":"177","author":"F Lu","year":"2000","unstructured":"Lu F, Selak M, O\u2019Connor J, Croul S, Lorenzana C, Butunoi C et al (2000) Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 177(2):95\u2013103","journal-title":"J Neurol Sci"},{"issue":"4","key":"2161_CR98","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0893-133X(00)00208-6","volume":"24","author":"JL Madrigal","year":"2001","unstructured":"Madrigal JL, Olivenza R, Moro MA, Lizasoain I, Lorenzo P, Rodrigo J et al (2001) Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology 24(4):420\u2013429","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"2161_CR99","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/brain\/awp046","volume":"132","author":"DJ Mahad","year":"2009","unstructured":"Mahad DJ, Ziabreva I, Campbell G, Lax N, White K, Hanson PS et al (2009) Mitochondrial changes within axons in multiple sclerosis. Brain 132(5):1161\u20131174","journal-title":"Brain"},{"key":"2161_CR100","doi-asserted-by":"crossref","unstructured":"Malinska D, Kulawiak B, Kudin AP, Kovacs R, Huchzermeyer C, Kann O, et al. Complex III-dependent superoxide production of brain mitochondria contributes to seizure-related ROS formation. Biochimica et Biophysica Acta (BBA)-Bioenergetics. 1797(6\u20137):1163\u201370.","DOI":"10.1016\/j.bbabio.2010.03.001"},{"issue":"1","key":"2161_CR101","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3233\/JAD-2006-10110","volume":"10","author":"M Mancuso","year":"2006","unstructured":"Mancuso M, Coppede F, Migliore L, Siciliano G, Murri L (2006) Mitochondrial dysfunction, oxidative stress and neurodegeneration. J Alzheimers Dis 10(1):59\u201373","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"2161_CR102","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2174\/138945010790031018","volume":"11","author":"M Mancuso","year":"2010","unstructured":"Mancuso M, Orsucci D, Volpi L, Calsolaro V, Siciliano G (2010) Coenzyme Q10 in neuromuscular and neurodegenerative disorders. Curr Drug Targets 11(1):111\u2013121","journal-title":"Curr Drug Targets"},{"issue":"2","key":"2161_CR103","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/S0887-8994(99)00038-7","volume":"21","author":"J Marin-Garcia","year":"1999","unstructured":"Marin-Garcia J, Ananthakrishnan R, Goldenthal MJ, Filiano JJ, Sarnat HB (1999) Skeletal muscle mitochondrial defects in nonspecific neurologic disorders. Pediatr Neurol 21(2):538\u2013542","journal-title":"Pediatr Neurol"},{"issue":"15","key":"2161_CR104","doi-asserted-by":"publisher","first-page":"8892","DOI":"10.1073\/pnas.95.15.8892","volume":"95","author":"RT Matthews","year":"1998","unstructured":"Matthews RT, Yang L, Browne S, Baik M, Beal MF (1998) Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci 95(15):8892\u20138897","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"2161_CR105","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1212\/WNL.0000000000003478","volume":"88","author":"A McGarry","year":"2017","unstructured":"McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K et al (2017) A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology 88(2):152\u2013159","journal-title":"Neurology"},{"issue":"6","key":"2161_CR106","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0197-0186(01)00125-5","volume":"40","author":"FM Menzies","year":"2002","unstructured":"Menzies FM, Ince PG, Shaw PJ (2002a) Mitochondrial involvement in amyotrophic lateral sclerosis. Neurochem Int 40(6):543\u2013551","journal-title":"Neurochem Int"},{"issue":"7","key":"2161_CR107","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1093\/brain\/awf167","volume":"125","author":"FM Menzies","year":"2002","unstructured":"Menzies FM, Cookson MR, Taylor RW, Turnbull DM, Chrzanowska-Lightowlers ZM, Dong L et al (2002b) Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. Brain 125(7):1522\u20131533","journal-title":"Brain"},{"issue":"5","key":"2161_CR108","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","volume":"64","author":"KR Merikangas","year":"2007","unstructured":"Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M et al (2007) Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 64(5):543\u2013552","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"2161_CR109","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","volume":"68","author":"KR Merikangas","year":"2011","unstructured":"Merikangas KR, Jin R, He J-P, Kessler RC, Lee S, Sampson NA et al (2011) Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 68(3):241\u2013251","journal-title":"Arch Gen Psychiatry"},{"key":"2161_CR110","doi-asserted-by":"crossref","unstructured":"Mirrione MM, Tsirka SE. A functional role for microglia in epilepsy. Clinical and Genetic Aspects of Epilepsy: IntechOpen; 2011.","DOI":"10.1155\/2011\/369295"},{"key":"2161_CR111","doi-asserted-by":"publisher","first-page":"175628641881907","DOI":"10.1177\/1756286418819074","volume":"12","author":"M Moccia","year":"2019","unstructured":"Moccia M, Capacchione A, Lanzillo R, Carbone F, Micillo T, Perna F et al (2019) Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-\u03b21a-treated multiple sclerosis. Ther Adv Neurol Disord 12:1756286418819074","journal-title":"Ther Adv Neurol Disord"},{"issue":"8\u20139","key":"2161_CR112","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s007020070050","volume":"107","author":"J Molina","year":"2000","unstructured":"Molina J, De Bustos F, Jim\u00e9nez-Jim\u00e9nez F, G\u00f3mez-Escalonilla C, Garc\u00eda-Redondo A, Esteban J et al (2000) Serum levels of coenzyme Q 10 in patients with amyotrophic lateral sclerosis. J Neural Transm 107(8\u20139):1021\u20131026","journal-title":"J Neural Transm"},{"issue":"18","key":"2161_CR113","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.jacc.2008.07.044","volume":"52","author":"SL Molyneux","year":"2008","unstructured":"Molyneux SL, Florkowski CM, George PM, Pilbrow AP, Frampton CM, Lever M et al (2008) Coenzyme Q10: an independent predictor of mortality in chronic heart failure. J Am Coll Cardiol 52(18):1435\u20131441","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2161_CR114","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.expneurol.2005.07.012","volume":"196","author":"PI Moreira","year":"2005","unstructured":"Moreira PI, Santos MS, Sena C, Nunes E, Sei\u00e7a R, Oliveira CR (2005) CoQ10 therapy attenuates amyloid \u03b2-peptide toxicity in brain mitochondria isolated from aged diabetic rats. Exp Neurol 196(1):112\u2013119","journal-title":"Exp Neurol"},{"key":"2161_CR115","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.psychres.2018.03.061","volume":"265","author":"E Mousavinejad","year":"2018","unstructured":"Mousavinejad E, Ghaffari MA, Riahi F, Hajmohammadi M, Tiznobeyk Z, Mousavinejad M (2018) Coenzyme Q10 supplementation reduces oxidative stress and decreases antioxidant enzyme activity in children with autism spectrum disorders. Psychiatry Res 265:62\u201369","journal-title":"Psychiatry Res"},{"issue":"3","key":"2161_CR116","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0304-3940(03)00185-X","volume":"341","author":"T M\u00fcller","year":"2003","unstructured":"M\u00fcller T, B\u00fcttner T, Gholipour A-F, Kuhn W (2003) Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson\u2019s disease. Neurosci Lett 341(3):201\u2013204","journal-title":"Neurosci Lett"},{"issue":"41","key":"2161_CR117","doi-asserted-by":"publisher","first-page":"14311","DOI":"10.1523\/JNEUROSCI.0499-12.2012","volume":"32","author":"C-H Ng","year":"2012","unstructured":"Ng C-H, Guan MS, Koh C, Ouyang X, Yu F, Tan E-K et al (2012) AMP kinase activation mitigates dopaminergic dysfunction and mitochondrial abnormalities in Drosophila models of Parkinson\u2019s disease. J Neurosci 32(41):14311\u201314317","journal-title":"J Neurosci"},{"issue":"1","key":"2161_CR118","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/0004867412449303","volume":"47","author":"AA Nierenberg","year":"2013","unstructured":"Nierenberg AA, Kansky C, Brennan BP, Shelton RC, Perlis R, Iosifescu DV (2013) Mitochondrial modulators for bipolar disorder: a pathophysiologically informed paradigm for new drug development. Aust N Z J Psychiatry 47(1):26\u201342","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"2161_CR119","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/088307380001500110","volume":"15","author":"A Nissenkorn","year":"2000","unstructured":"Nissenkorn A, Zeharia A, Lev D, Watemberg N, Fattal-Valevski A, Barash V et al (2000) Neurologic presentations of mitochondrial disorders. J Child Neurol 15(1):44\u201348","journal-title":"J Child Neurol"},{"issue":"1","key":"2161_CR120","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1212\/01.wnl.0000250355.28474.8e","volume":"68","author":"NN-P Investigators","year":"2007","unstructured":"NN-P Investigators (2007) A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease. Neurology. 68(1):20\u20138","journal-title":"Neurology."},{"issue":"3","key":"2161_CR121","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1017\/S0012162205000332","volume":"47","author":"G Oliveira","year":"2005","unstructured":"Oliveira G, Diogo L, Grazina M, Garcia P, Ataide A, Marques C et al (2005) Mitochondrial dysfunction in autism spectrum disorders: a population-based study. Dev Med Child Neurol 47(3):185\u2013189","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"2161_CR122","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1001\/archneur.63.6.883","volume":"63","author":"JS Paulsen","year":"2006","unstructured":"Paulsen JS, Hayden M, Stout JC, Langbehn DR, Aylward E, Ross CA et al (2006) Preparing for preventive clinical trials: the Predict-HD study. Arch Neurol 63(6):883\u2013890","journal-title":"Arch Neurol"},{"issue":"11","key":"2161_CR123","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.3390\/ijms18112365","volume":"18","author":"JN Pearson-Smith","year":"2017","unstructured":"Pearson-Smith JN, Patel M (2017) Metabolic dysfunction and oxidative stress in epilepsy. Int J Mol Sci 18(11):2365","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2161_CR124","doi-asserted-by":"publisher","first-page":"334","DOI":"10.4103\/0253-7613.71884","volume":"42","author":"S Prakash","year":"2010","unstructured":"Prakash S, Sunitha J, Hans M (2010) Role of coenzyme Q10 as an antioxidant and bioenergizer in periodontal diseases. Indian J Pharmacol 42(6):334","journal-title":"Indian J Pharmacol"},{"key":"2161_CR125","first-page":"35","volume":"13","author":"S Przedborski","year":"1998","unstructured":"Przedborski S, Jackson-Lewis V (1998) Mechanisms of MPTP toxicity. Movement Disorders 13:35\u201338","journal-title":"Movement Disorders"},{"issue":"1\u20134","key":"2161_CR126","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/biof.5520320113","volume":"32","author":"C Quinzii","year":"2008","unstructured":"Quinzii C, Naini A, DiMauro S, Hirano M (2008) Human CoQ_ 10 deficiencies. BioFactors 32(1\u20134):113\u2013118","journal-title":"BioFactors"},{"issue":"3","key":"2161_CR127","first-page":"157","volume":"3","author":"BL Rollins","year":"2017","unstructured":"Rollins BL, Morgan L, Hjelm BE, Sequeira A, Schatzberg AF, Barchas JD et al (2017) Mitochondrial complex I deficiency in schizophrenia and bipolar disorder and medication influence. Molecular Neuropsychiatry 3(3):157\u2013169","journal-title":"Molecular Neuropsychiatry"},{"key":"2161_CR128","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1016\/S1353-8020(09)70800-4","volume":"15","author":"CA Ross","year":"2009","unstructured":"Ross CA, Shoulson I (2009) Huntington disease: pathogenesis, biomarkers, and approaches to experimental therapeutics. Parkinsonism Relat Disord 15:S135\u2013S138","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"2161_CR129","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/mp.2010.136","volume":"17","author":"D Rossignol","year":"2012","unstructured":"Rossignol D, Frye R (2012) Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry 17(3):290\u2013314","journal-title":"Mol Psychiatry"},{"issue":"2","key":"2161_CR130","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/ng1097-215","volume":"17","author":"A R\u00f6tig","year":"1997","unstructured":"R\u00f6tig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D et al (1997) Aconitase and mitochondrial iron\u2013sulphur protein deficiency in Friedreich ataxia. Nat Genet 17(2):215\u2013217","journal-title":"Nat Genet"},{"issue":"3","key":"2161_CR131","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4306\/pi.2017.14.3.271","volume":"14","author":"S-H Ryu","year":"2017","unstructured":"Ryu S-H, Jung H-Y, Lee KJ, Moon SW, Lee DW, Hong N et al (2017) Incidence and course of depression in patients with Alzheimer\u2019s disease. Psychiatry Investig 14(3):271","journal-title":"Psychiatry Investig"},{"key":"2161_CR132","first-page":"13","volume":"6","author":"JN Samsom","year":"2015","unstructured":"Samsom JN, Wong AH (2015) Schizophrenia and depression co-morbidity: what we have learned from animal models. Front Psych 6:13","journal-title":"Front Psych"},{"issue":"11","key":"2161_CR133","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3109\/00207454.2013.801844","volume":"123","author":"M Sanoobar","year":"2013","unstructured":"Sanoobar M, Eghtesadi S, Azimi A, Khalili M, Jazayeri S, Reza GM (2013) Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing\u2013remitting multiple sclerosis. Int J Neurosci 123(11):776\u2013782","journal-title":"Int J Neurosci"},{"issue":"3","key":"2161_CR134","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1179\/1476830515Y.0000000002","volume":"19","author":"M Sanoobar","year":"2016","unstructured":"Sanoobar M, Dehghan P, Khalili M, Azimi A, Seifar F (2016) Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: a double blind randomized clinical trial. Nutr Neurosci 19(3):138\u2013143","journal-title":"Nutr Neurosci"},{"key":"2161_CR135","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.lfs.2015.11.006","volume":"145","author":"SSS Saravi","year":"2016","unstructured":"Saravi SSS, Dehpour AR (2016) Potential role of organochlorine pesticides in the pathogenesis of neurodevelopmental, neurodegenerative, and neurobehavioral disorders: a review. Life Sci 145:255\u2013264","journal-title":"Life Sci"},{"key":"2161_CR136","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.yebeh.2014.05.024","volume":"37","author":"E Sattarinezhad","year":"2014","unstructured":"Sattarinezhad E, Shafaroodi H, Sheikhnouri K, Mousavi Z, Moezi L (2014) The effects of coenzyme Q10 on seizures in mice: the involvement of nitric oxide. Epilepsy Behav 37:36\u201342","journal-title":"Epilepsy Behav"},{"issue":"3","key":"2161_CR137","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/6772","volume":"21","author":"M Schuelke","year":"1999","unstructured":"Schuelke M, Smeitink J, Mariman E, Loeffen J, Plecko B, Trijbels F et al (1999) Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat Genet 21(3):260\u2013261","journal-title":"Nat Genet"},{"issue":"3","key":"2161_CR138","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0167-4943(92)90060-H","volume":"15","author":"U Senin","year":"1992","unstructured":"Senin U, Parnetti L, Barbagallo-Sangiorgi G, Bartorelli L, Bocola V, Capurso A et al (1992) Idebenone in senile dementia of Alzheimer type: a multicentre study. Arch Gerontol Geriatr 15(3):249\u2013260","journal-title":"Arch Gerontol Geriatr"},{"key":"2161_CR139","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fpsyt.2018.00334","volume":"9","author":"M Shadrina","year":"2018","unstructured":"Shadrina M, Bondarenko EA, Slominsky PA (2018) Genetics factors in major depression disease. Front Psych 9:334","journal-title":"Front Psych"},{"issue":"4","key":"2161_CR140","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/0883073809342128","volume":"25","author":"J Shoffner","year":"2010","unstructured":"Shoffner J, Hyams L, Langley GN, Cossette S, Mylacraine L, Dale J et al (2010) Fever plus mitochondrial disease could be risk factors for autistic regression. J Child Neurol 25(4):429\u2013434","journal-title":"J Child Neurol"},{"issue":"19","key":"2161_CR141","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.2174\/0929867033456882","volume":"10","author":"CW Shults","year":"2003","unstructured":"Shults CW (2003) Coenzyme Q10 in neurodegenerative diseases. Curr Med Chem 10(19):1917\u20131921","journal-title":"Curr Med Chem"},{"key":"2161_CR142","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/ana.410420221","volume":"42","author":"CW Shults","year":"1997","unstructured":"Shults CW, Haas RH, Passov D, Beal MF (1997) Coenzyme Q10 levels correlate with the activities of complexes I and II\/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann Neurol 42:261\u20134","journal-title":"Ann Neurol"},{"issue":"3","key":"2161_CR143","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1212\/WNL.50.3.793","volume":"50","author":"CW Shults","year":"1998","unstructured":"Shults CW, Beal MF, Fontaine D, Nakano K, Haas R (1998) Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in parkinsonian patients. Neurology 50(3):793\u2013795","journal-title":"Neurology"},{"issue":"10","key":"2161_CR144","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","volume":"59","author":"CW Shults","year":"2002","unstructured":"Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S et al (2002) Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol 59(10):1541\u20131550","journal-title":"Arch Neurol"},{"issue":"6","key":"2161_CR145","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.bbadis.2006.03.004","volume":"1762","author":"KM Smith","year":"2006","unstructured":"Smith KM, Matson S, Matson WR, Cormier K, Del Signore SJ, Hagerty SW et al (2006) Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington\u2019s disease mice. Biochim Biophys Acta. 1762(6):616\u201326","journal-title":"Biochim Biophys Acta."},{"issue":"1","key":"2161_CR146","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jns.2004.09.030","volume":"228","author":"M Sohmiya","year":"2005","unstructured":"Sohmiya M, Tanaka M, Suzuki Y, Tanino Y, Okamoto K, Yamamoto Y (2005) An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients. J Neurol Sci 228(1):49\u201353","journal-title":"J Neurol Sci"},{"issue":"4","key":"2161_CR147","first-page":"203","volume":"18","author":"M Soleimani","year":"2014","unstructured":"Soleimani M, Jameie SB, Barati M, Mehdizadeh M, Kerdari M (2014) Effects of coenzyme Q10 on the ratio of TH1\/TH2 in experimental autoimmune encephalomyelitis model of multiple sclerosis in C57BL\/6. Iran Biomed J 18(4):203","journal-title":"Iran Biomed J"},{"issue":"3","key":"2161_CR148","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.nbd.2004.10.021","volume":"18","author":"M Somayajulu","year":"2005","unstructured":"Somayajulu M, McCarthy S, Hung M, Sikorska M, Borowy-Borowski H, Pandey S (2005) Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10. Neurobiol Dis 18(3):618\u2013627","journal-title":"Neurobiol Dis"},{"key":"2161_CR149","first-page":"597","volume":"5","author":"M Spindler","year":"2009","unstructured":"Spindler M, Beal MF, Henchcliffe C (2009) Coenzyme Q10 effects in neurodegenerative disease. Neuropsychiatr Dis Treat 5:597","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2161_CR150","doi-asserted-by":"crossref","unstructured":"Stack EC, Smith KM, Ryu H, Cormier K, Chen M, Hagerty SW, et al. (2006) Combination therapy using minocycline and coenzyme Q10 in R6\/2 transgenic Huntington's disease mice. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 1762(3):373\u201380.","DOI":"10.1016\/j.bbadis.2005.11.002"},{"issue":"7","key":"2161_CR151","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/mp.2017.47","volume":"22","author":"P Steullet","year":"2017","unstructured":"Steullet P, Cabungcal JH, Coyle J, Didriksen M, Gill K, Grace AA et al (2017) Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia. Mol Psychiatry 22(7):936\u2013943","journal-title":"Mol Psychiatry"},{"issue":"12","key":"2161_CR152","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1007\/s00115-007-2285-1","volume":"78","author":"A Storch","year":"2007","unstructured":"Storch A, Koenzym Q (2007) 10 beim Morbus Parkinson. Nervenarzt 78(12):1378\u20131382","journal-title":"Nervenarzt"},{"key":"2161_CR153","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0098-2997(97)00008-3","volume":"18","author":"E Strijks","year":"1997","unstructured":"Strijks E, Kremer H, Horstink M (1997) Q10 therapy in patients with idiopathic Parkinson\u2019s disease. Mol Aspects Med 18:237\u2013240","journal-title":"Mol Aspects Med"},{"key":"2161_CR154","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.nbd.2013.01.006","volume":"54","author":"G Tang","year":"2013","unstructured":"Tang G, Rios PG, Kuo S-H, Akman HO, Rosoklija G, Tanji K et al (2013) Mitochondrial abnormalities in temporal lobe of autistic brain. Neurobiol Dis 54:349\u2013361","journal-title":"Neurobiol Dis"},{"issue":"4","key":"2161_CR155","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.yebeh.2011.09.018","volume":"22","author":"MK Tawfik","year":"2011","unstructured":"Tawfik MK (2011) Coenzyme Q10 enhances the anticonvulsant effect of phenytoin in pilocarpine-induced seizures in rats and ameliorates phenytoin-induced cognitive impairment and oxidative stress. Epilepsy Behav 22(4):671\u2013677","journal-title":"Epilepsy Behav"},{"key":"2161_CR156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/6509493","volume":"2017","author":"HL Teoh","year":"2017","unstructured":"Teoh HL, Carey K, Sampaio H, Mowat D, Roscioli T, Farrar M (2017) Inherited paediatric motor neuron disorders: beyond spinal muscular atrophy. Neural plasticity. 2017:1\u201322","journal-title":"Neural plasticity."},{"issue":"11","key":"2161_CR157","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1212\/01.WNL.0000096376.03678.C1","volume":"61","author":"L Thal","year":"2003","unstructured":"Thal L, Grundman M, Berg J, Ernstrom K, Margolin R, Pfeiffer E et al (2003) Idebenone treatment fails to slow cognitive decline in Alzheimer\u2019s disease. Neurology 61(11):1498\u20131502","journal-title":"Neurology"},{"issue":"6","key":"2161_CR158","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.coi.2011.09.003","volume":"23","author":"H-C von B\u00fcdingen","year":"2011","unstructured":"von B\u00fcdingen H-C, Bar-Or A, Zamvil SS (2011) B cells in multiple sclerosis: connecting the dots. Curr Opin Immunol 23(6):713\u2013720","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"2161_CR159","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3233\/JAD-2008-14210","volume":"14","author":"TL Wadsworth","year":"2008","unstructured":"Wadsworth TL, Bishop JA, Pappu AS, Woltjer RL, Quinn JF (2008) Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer\u2019s disease. J Alzheimers Dis 14(2):225\u2013234","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"2161_CR160","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000119366","volume":"36","author":"G Weyer","year":"1997","unstructured":"Weyer G, Babej-D\u00f6lle R, Hadler D, Hofmann S, Herrmann W (1997) A controlled study of 2 doses of idebenone in the treatment of Alzheimer\u2019s disease. Neuropsychobiology 36(2):73\u201382","journal-title":"Neuropsychobiology"},{"issue":"4","key":"2161_CR161","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ng0897-352","volume":"16","author":"RB Wilson","year":"1997","unstructured":"Wilson RB, Roof DM (1997) Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue. Nat Genet 16(4):352\u2013357","journal-title":"Nat Genet"},{"issue":"11","key":"2161_CR162","doi-asserted-by":"publisher","first-page":"e27985","DOI":"10.1371\/journal.pone.0027985","volume":"6","author":"TS Wingo","year":"2011","unstructured":"Wingo TS, Cutler DJ, Yarab N, Kelly CM, Glass JD (2011) The heritability of amyotrophic lateral sclerosis in a clinically ascertained United States research registry. PloS one. 6(11):e27985","journal-title":"PloS one."},{"issue":"1","key":"2161_CR163","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrn3617","volume":"15","author":"DN Xanthos","year":"2014","unstructured":"Xanthos DN, Sandk\u00fchler J (2014) Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity. Nat Rev Neurosci 15(1):43\u201353","journal-title":"Nat Rev Neurosci"},{"key":"2161_CR164","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.expneurol.2013.12.017","volume":"253","author":"ES Yamada","year":"2014","unstructured":"Yamada ES, Respondek G, M\u00fcssner S, De Andrade A, H\u00f6llerhage M, Depienne C et al (2014) Annonacin, a natural lipophilic mitochondrial complex I inhibitor, increases phosphorylation of tau in the brain of FTDP-17 transgenic mice. Exp Neurol 253:113\u2013125","journal-title":"Exp Neurol"},{"issue":"2","key":"2161_CR165","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12031-007-9033-7","volume":"34","author":"X Yang","year":"2008","unstructured":"Yang X, Yang Y, Li G, Wang J, Yang ES (2008) Coenzyme Q10 attenuates \u03b2-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation. J Mol Neurosci 34(2):165\u2013171","journal-title":"J Mol Neurosci"},{"issue":"5","key":"2161_CR166","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1111\/j.1471-4159.2009.06074.x","volume":"109","author":"L Yang","year":"2009","unstructured":"Yang L, Calingasan NY, Wille EJ, Cormier K, Smith K, Ferrante RJ et al (2009) Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson\u2019s and Huntington\u2019s diseases. J Neurochem 109(5):1427\u20131439","journal-title":"J Neurochem"},{"issue":"5","key":"2161_CR167","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1007\/s12035-016-9959-2","volume":"54","author":"M Ying","year":"2017","unstructured":"Ying M, Sui X, Zhang Y, Sun Q, Qu Z, Luo X et al (2017) Identification of novel key molecules involved in spatial memory impairment in triple transgenic mice of Alzheimer\u2019s disease. Mol Neurobiol 54(5):3843\u20133858","journal-title":"Mol Neurobiol"},{"issue":"4","key":"2161_CR168","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00204-018-2163-6","volume":"92","author":"H Yu","year":"2018","unstructured":"Yu H, Wang D, Zou L, Zhang Z, Xu H, Zhu F et al (2018) Proteomic alterations of brain subcellular organelles caused by low-dose copper exposure: implication for Alzheimer\u2019s disease. Arch Toxicol 92(4):1363\u20131382","journal-title":"Arch Toxicol"},{"issue":"1","key":"2161_CR169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Cao Z, Yang M, Xi X, Guo Y, Fang M et al (2017) Comorbid generalized anxiety disorder and its association with quality of life in patients with major depressive disorder. Sci Rep 7(1):1\u20138","journal-title":"Sci Rep"},{"issue":"1","key":"2161_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-020-00406-3","volume":"15","author":"E Zucchi","year":"2020","unstructured":"Zucchi E, Bonetto V, Sorar\u00f9 G, Martinelli I, Parchi P, Liguori R et al (2020) Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers. Mol Neurodegener 15(1):1\u201320","journal-title":"Mol Neurodegener"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-021-02161-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-021-02161-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-021-02161-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T03:37:46Z","timestamp":1725853066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-021-02161-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":170,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["2161"],"URL":"https:\/\/doi.org\/10.1007\/s00210-021-02161-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,1]]},"assertion":[{"value":"18 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"On behalf of all authors, we give full consent to publish.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}